SureyyaSavasanMD

Pediatric Hematology & Oncology • Detroit, MI

Associate Professor, Pediatrics, Wayne State University School of Medicine

Join to view full profile

Dr. Savasan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Savasan's full profile

Already have an account?

Office
Childrens Hospital Mi Hematology/Oncology
3901 Beaubien 3rd Floor - Carl's Building
Detroit, MI 48201
Phone+1 313-745-5516

Education & Training

Children's Hospital of MichiganFellowship, Pediatric Hematology/Oncology, 1994 - 1998
Hacettepe University FOMClass of 1984

Certifications & Licensure

MI State Medical License 1994 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease Start of enrollment: 2007 Jan 01
No longer available
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
Completed
Phase 2, Phase 3
Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET) Start of enrollment: 2011 Feb 01
Unknown status
Not Applicable
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
Completed
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia Start of enrollment: 2013 Jun 24
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

43 citations
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies.
Kirk R. Schultz, Amina Kariminia, Bernard Ng, Sayeh Abdossamadi, Madeline Lauener
Blood. 2020-04-09
43 citations
Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survival
R. Lamba, E. Abella, D Kukuruga, J. Klein, Süreyya Savaşan
Leukemia. 2004-10-01
10 citations
Flow cytometry for assessment of the tumor microenvironment in pediatric Hodgkin lymphoma.
Meret Henry, Steven Buck, Süreyya Savaşan
Pediatric Blood & Cancer. 2018-11-01

Press Mentions

New Treatment for Children with Blood Disorders Comes to MichiganSeptember 25th, 2024
Teen Boy First in Michigan to Get Gene Editing Treatment for Blood DisorderSeptember 24th, 2024
DMC Hospital Starts New Gene Treatments for Blood DisordersSeptember 23rd, 2024